FIELD: pharmaceutical industry, in particular pharmaceutical preparation in ointment form for treatment of foul wounds.
SUBSTANCE: claimed agent contains as active ingredient combination of antibacterial agent dioxidine; methyluracil as agent accelerating cell regeneration; lidoxaine hydrochloride as topical anesthetic agent and polyethylene oxide 400 and 1500 as carrier in ratio of 1:4:2:(3.5-3.6):1, respectively. Claimed agent may be used in the first step of wound process.
EFFECT: agent having minimal collateral effect due to application of low toxic components.
3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF SUPPURATIVE-NECROTIC PROCESSES | 1998 |
|
RU2145497C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2646462C1 |
METHOD OF PREPARING "DIOXYCOL" OINTMENT | 1997 |
|
RU2138250C1 |
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
COMPOSITION ELICITING ANTISEPTIC, REPARATIVE AND ANALGETIC PROPERTIES | 2000 |
|
RU2177314C2 |
LOCAL PHARMACEUTICAL ANTIBACTERIAL COMPOSITION OF ACTIVE BIOMETALLIC COMPLEXES | 2011 |
|
RU2489147C2 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2601897C1 |
PREPARATION FOR TREATMENT OF INFECTED SLAGGISH-HEALING WOUND AND ULCER | 1992 |
|
RU2054924C1 |
Authors
Dates
2006-09-10—Published
2004-10-08—Filed